Drugs for Cellulitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 107)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Cephalexin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
15686-71-2 |
27447 |
Synonyms:
(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
66873
7-(D-a-Aminophenylacetamido)desacetoxycephalosporanate
7-(D-a-Aminophenylacetamido)desacetoxycephalosporanic acid
7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanate
7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid
7-(D-Α-aminophenylacetamido)desacetoxycephalosporanate
7-(D-Α-aminophenylacetamido)desacetoxycephalosporanic acid
7-b-(D-a-Amino-a-phenylacetylamino)-3-methyl-3-cephem-4-carboxylate
7-b-(D-a-Amino-a-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylate
7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
7-Β-(D-α-amino-α-phenylacetylamino)-3-methyl-3-cephem-4-carboxylate
7-Β-(D-α-amino-α-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
Anhydrous cefalexin
Anhydrous cephalexin
Cefalessina
Cefalexin
Cefalexin anhydrous
Cefalexina
Cefalexine
Céfalexine
Cefalexinum
Celexin
Cepastar
Cepexin
Cephacillin
CEPHALEXIN
Cephalexin 1-hydrate
Cephalexin anhydrous
|
Cephalexin dihydride
Cephalexin hemihydrate
Cephalexin hydrate
Cephalexin hydrochloride
Cephalexin monohydrate
Cephalexin monohydrochloride
Cephalexin monohydrochloride, monohydrate
Cephalexin, (6R-(6alpha,7alpha(r*)))-isomer
Cephalexin, (6R-(6alpha,7beta(s*)))-isomer
Cephalexin, (6R-(6alpha,7beta))-isomer
Cephalexin, monosodium salt
Cephalexin, monosodium salt, (6R-(6alpha,7beta))-isomer
Cephalexine
Cephalexinum
CEPOREX
Ceporexin
Ceporexine
CEX
Dihydride, cephalexin
Hemihydrate, cephalexin
Hydrochloride, cephalexin
KEFLET
Keflex
KEFTAB
Monohydrate cephalexin monohydrochloride
Monohydrate, cephalexin
Monohydrochloride, cephalexin
Monohydrochloride, monohydrate cephalexin
Monosodium salt cephalexin
Palitrex
|
|
2 |
|
Phenoxymethylpenicillin |
Approved, Vet_approved |
Phase 4 |
|
87-08-1 |
6869 |
Synonyms:
(2S,5R,6R)-3,3-DIMETHYL-7-oxo-6-(2-phenoxyacetamido)-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylate
(2S,5R,6R)-3,3-DIMETHYL-7-oxo-6-(2-phenoxyacetamido)-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylIC ACID
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6-Phenoxyacetamidopenicillanate
6-Phenoxyacetamidopenicillanic acid
Acipen V
Apocillin
Apopen
Beepen-Vk
Beromycin
Beromycin, penicillin
Berromycin, penicillin
Betapen
Betapen-Vk
Calcipen
Compocillin V
Crystapen V
Distaquaine V
Eskacillian V
Eskacillin V
Fenacilin
Fenospen
Fenossimetilpenicillina
Fenossimetilpenicillina [Dcit]
Fenoximetilpenicilina
Fenoximetilpenicilina [INN-Spanish]
Fenoxymethylpenicillin
Fenoxypen
Ledercillin Vk
Meropenin
Oracillin
Oratren
Ospen
PCV
Pen VK
PENAPAR-VK
Penicillin beromycin
Penicillin berromycin
Penicillin phenoxymethyl
Penicillin V
Penicillin V potassium
Penicillin V sodium
Penicillin VK
|
Penicillin, phenoxymethyl
PENICILLIN-VK
Pen-Oral
Pen-V
Pen-Vee
Pen-Vee K
Pfizerpen Vk
Phenocillin
PHENOMYCILLINE
Phenopenicillin
Phenoximethylpenicillinum
Phenoxomethylpenicillin
Phenoxymethyl penicillin
Phenoxymethylenepenicillinate
Phenoxymethylenepenicillinic acid
Phenoxymethylpenicillin
Phenoxymethylpenicillin potassium
Phenoxymethylpenicilline
Phénoxyméthylpénicilline
Phenoxymethylpenicillinic acid
Phenoxymethylpenicillinic acid potassium salt
Phenoxymethylpenicillinum
Potassium, penicillin V
PV
Robicillin
Rocilin
Sodium, penicillin V
Stabicillin
Uticillin Vk
V Cillin K
V Sodium, penicillin
V-Cil
V-Cillin
VCillin K
V-Cillin K
V-Cylina
V-Cyline
Vebecillin
VEETIDS
Veetids '125'
Veetids '250'
Veetids '500'
Vegacillin
V-Tablopen
|
|
3 |
|
Ceftaroline fosamil |
Approved, Investigational |
Phase 4 |
|
229016-73-3 |
72562361 |
Synonyms:
(6R,7R)-7-[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
4-{2-[(2-carboxy-7-{[2-(ethoxyimino)-2-[5-(hydrogen phosphonatoamino)-1,2,4-thiadiazol-3-yl]-1-hydroxyethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)sulphanyl]-1,3-thiazol-4-yl}-1-methylpyridin-1-ium
Ceftarolina fosamilo
|
Ceftaroline
Ceftaroline fosamil
Ceftarolinum fosamilum
|
|
4 |
|
Bacitracin |
Approved, Vet_approved |
Phase 4 |
|
1405-87-4 |
10909430 |
Synonyms:
A.L. labs brand OF bacitracin zinc salt
Ak tracin
Akorn brand OF bacitracin
Ak-tracin
ALBAC 50
Altracin
Baci im
Baci RX
BACIFERM 50
BACIGUENT
Baci-im
BACIIM
Baci-RX
Bacitin
Bacitracin
Bacitracin a
Bacitracin a2a
Bacitracin akorn brand
Bacitracin dioptic brand
BACITRACIN F, 1-(N-((2-(1-AMINO-2-METHYLBUTYL)-4,5-DIHYDRO-4-THIAZOLYL)CARBONYL)-L-LEUCINE)-
Bacitracin lee brand
Bacitracin mcneil brand
Bacitracin pharmascience brand
|
Bacitracin zinc
Bacitracin zinc complex
Bacitracin, zinc
Bacitracina
Bacitracine martinet
Ciba vision brand OF bacitracin
Dioptic brand OF bacitracin
E700
Lee brand OF bacitracin
Martinet, bacitracine
McNeil brand OF bacitracin
Ocu tracin
Ocumed brand OF bacitracin
Ocu-tracin
OcuTracin
Pharma tek brand OF bacitracin
Pharmascience brand OF bacitracin
Reed and carnrick brand OF bacitracin
Topitracin
Zeba RX
Zeba-RX
Zinc bacitracin
Zinc, bacitracin
|
|
5 |
|
Retapamulin |
Approved |
Phase 4 |
|
224452-66-8 |
6918462 |
Synonyms:
(1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0,]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl}acetic acid
(1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0,]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulphanyl}acetate
(1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0,]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulphanyl}acetic acid
(1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0¹,⁸]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl}acetic acid
(1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0¹,⁸]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulphanyl}acetate
(1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxotricyclo[5.4.3.0¹,⁸]tetradecan-6-yl 2-{[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulphanyl}acetic acid
AITABAX
|
Altabax
ALTARGO
Retapamulin
Retapamulina
SB 275833
SB-275833
|
|
6 |
|
Copper |
Approved, Investigational |
Phase 4 |
|
7440-50-8 |
27099 |
Synonyms:
cobre
COPPER (II) ion
Copper(II) cation
Copper, ion (cu2+)
Cu
Cu(2+)
|
Cu(II)
Cu2+
cuivre
Cupric ion
cuprum
Kupfer
|
|
7 |
|
Cantharidin |
Approved, Investigational |
Phase 4 |
|
56-25-7 |
2545 |
Synonyms:
1,2-Dimethyl-3,6-epoxyperhydrophthalic anhydride
CANTHARIDIN
Cantharidine
Cantharone
|
exo-1,2-cis-Dimethyl-3,6-epoxyhexahydrophthalic anhydride
Kantharidin
NSC-61805
|
|
8 |
|
Flucloxacillin |
Approved, Investigational |
Phase 4 |
|
5250-39-5, 34214-51-2 |
21319 |
Synonyms:
(2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillin
ABBOFLOX
BRL-2039
Floxacillin
Floxapen
FLUCLOMIX-250
FLUCLOMIX-500
Fluclox
Flucloxacilina
Flucloxacilina [INN-Spanish]
Flucloxacillin
FLUCLOXACILLIN SODIUM
Flucloxacilline
|
Flucloxacilline [INN-French]
Flucloxacillin-sodium
Flucloxacillinum
Flucloxacillinum [INN-Latin]
FLUCLOXIN
Fluorochloroxacillin
GALFLOXIN
LADROPEN
MFIPC
RIMAFLOX
Sesamol
STAFOXIL
STAPHLIPEN
ZOXIN 250
ZOXIN 500
|
|
9 |
|
Meticillin |
Approved, Investigational |
Phase 4 |
|
61-32-5 |
6087 |
Synonyms:
(2,6-Dimethoxyphenyl)penicillin
(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6-(2,6-Dimethoxybenzamido)penicillanic acid
6b-(2,6-Dimethoxybenzamido)penicillanate
6b-(2,6-Dimethoxybenzamido)penicillanic acid
6beta-(2,6-Dimethoxybenzamido)penicillanate
6beta-(2,6-Dimethoxybenzamido)penicillanic acid
6Β-(2,6-dimethoxybenzamido)penicillanate
6Β-(2,6-dimethoxybenzamido)penicillanic acid
CELPILLINA
CSL Brand OF methicillin sodium
Dimethoxyphenyl penicillin
METHICILLIN
|
Methicillin hydrate, monosodium salt
Methicillin monohydrate, monosodium salt
Methicillin sodium
Methicillinum
Methycillin
Meticilina
Meticillin
Meticillina
Meticilline
Meticillinum
Metin
Penicillin, dimethoxyphenyl
Staphcillin
|
|
10 |
|
Vancomycin |
Approved |
Phase 4 |
|
1404-90-6 |
14969 |
Synonyms:
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(2.2SP,3.5SA,2.6SP)-O(4.2),C(3.4)
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-b-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-b-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-β-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-β-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
Abbott brand OF vancomycin hydrochloride
AB-vancomycin
Azupharma brand OF vancomycin hydrochloride
C(5.4),O(4.6)
Cell pharm brand OF vancomycin hydrochloride
Chiesi brand OF vancomycin hydrochloride
Combino brand OF vancomycin hydrochloride
Curasan brand OF vancomycin hydrochloride
Dakota brand OF vancomycin hydrochloride
Diatracin
Dista brand OF vancomycin hydrochloride
Eli lilly brand OF vancomycin hydrochloride
Hexal brand OF vancomycin hydrochloride
Hydrochloride, vancomycin
Lilly brand OF vancomycin hydrochloride
MIP brand OF vancomycin hydrochloride
Norman brand OF vancomycin hydrochloride
Ratiopharm brand OF vancomycin hydrochloride
|
Sulfate, vancomycin
Vanco azupharma
Vanco-cell
Vancocin
Vancocin HCL
Vancocine
VANCOLED
Vancomicin
Vancomicina
Vancomicina abbott
Vancomicina chiesi
Vancomicina combino phar
Vancomicina norman
VANCOMYCIN
Vancomycin HCL
Vancomycin hexal
Vancomycin hydrochloride
Vancomycin lilly
Vancomycin phosphate (1:2)
Vancomycin phosphate (1:2), decahydrate
Vancomycin sulfate
Vancomycine
Vancomycine dakota
Vancomycin-ratiopharm
Vancomycinum
VANCOR
Vanco-saar
|
|
11 |
|
Daptomycin |
Approved, Investigational |
Phase 4 |
|
103060-53-3 |
16129629 |
Synonyms:
CUBICIN
CUBICIN RF
Daptomicina
Daptomycin
Daptomycine
|
Daptomycinum
LY 146032
LY-146032
LY-164032
|
|
12 |
|
Dalbavancin |
Approved, Investigational |
Phase 4 |
|
171500-79-1 |
16134627 |
Synonyms:
5,31-DICHLORO-38-DE(METHOXYCARBONYL)-7-DEMETHYL-19-DEOXY-56-O [2-DEOXY-2-[(10-METHYLUNDECANOYL)AMINO]-Β-D-GLUCOPYRANURONOSYL]-38-[[3-(DIMETHYLAMINO)PROPYL] CARBAMOYL]-42-O-Α-D-MANNOPYRANOSYL-15-N-METHYL(RISTOMYCIN A AGLYCONE) HYDROCHLORIDE
A-A-1
BI 397
BI397
BI-397
DALBAVANCIN
DALBAVANCIN B0
|
Dalbavancina
MDL-64397
VER001
VER-001
VERO001
ZEVEN
|
|
13 |
|
beta-Lactams |
|
Phase 4 |
|
|
|
14 |
|
Lactams |
|
Phase 4 |
|
|
|
15 |
|
Penicillins |
|
Phase 4 |
|
|
|
16 |
|
Anti-Infective Agents, Local |
|
Phase 4 |
|
|
|
17 |
|
Copper Supplement |
|
Phase 4 |
|
|
|
18 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
19 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
20 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
21 |
|
Probenecid |
Approved, Investigational |
Phase 3 |
|
57-66-9 |
4911 |
Synonyms:
4-((Dipropylamino)sulfonyl)benzoate
4-((Dipropylamino)sulfonyl)benzoic acid
4-((Dipropylamino)sulphonyl)benzoate
4-((Dipropylamino)sulphonyl)benzoic acid
4-(Di-N-propylsulfamoyl)benzoesaeure
4-(Di-n-propylsulfamoyl)benzoesäure
4-(Di-N-propylsulphamoyl)benzoesaeure
4-(N,N-Dipropylsulfamoyl)benzoesaeure
4-(N,N-Dipropylsulfamoyl)benzoesäure
4-(N,N-Dipropylsulphamoyl)benzoesaeure
Apurina
Benecid
Benemid
Benuryl
Biokanol brand OF probenecid
Colbenemid
Col-Probenecid
HC 5006
ICN brand OF probenecid
IDIS brand OF probenecid
Major brand OF probenecid
Martec brand OF probenecid
Merck brand OF probenecid
NSC-18786
Ophthalmic brand OF probenecid
p-(Dipropylsulfamoyl)benzoate
p-(Dipropylsulfamoyl)benzoic acid
p-(Dipropylsulphamoyl)benzoate
p-(Dipropylsulphamoyl)benzoic acid
|
Parmed brand OF probenecid
Polycillin-PRB
PROBALAN
Probalan®
Probampacin
PROBAMPICIN
Probecid
Proben
Proben-C
PROBENECID
Probenecid acid
Probenecid major brand
Probenecid martec brand
Probenecid parmed brand
Probenecid weimer
Probenecid zenith brand
Probenecida
Probenecide
Probenecidum
Probenemid
Probenicid
Probexin
Pro-cid
Prolongine
Synergid R
Tubophan
Uricosid
Valdecasas brand OF probenecid
Zenith brand OF probenecid
|
|
22 |
|
Moxifloxacin |
Approved, Investigational |
Phase 3 |
|
186826-86-8, 354812-41-2, 151096-09-2 |
152946 |
Synonyms:
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Actira
Avalox
Avelox
AVELOX I.V.
BAY 12-8039
|
Izilox
MOXIFLOXACIN
Moxifloxacin HCl
Moxifloxacin hydrochloride
Moxifloxacino
Octegra
Proflox
VIGAMOX
|
|
23 |
|
Oritavancin |
Approved, Investigational |
Phase 3 |
|
171099-57-3 |
16136912 |
Synonyms:
CHLOROBIPHENYL-CHLOROEREMOMYCIN
LY333328
|
|
|
24 |
|
Telavancin |
Approved |
Phase 3 |
|
372151-71-8 |
21014972 3081362 |
Synonyms:
5,15-Dichloro-48-({3-[(4-{[2-(decylamino)ethyl]amino}-5-hydroxy-4,6-dimethyloxan-2-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl}oxy)-2,18,20,23,26,32,35,37,42,44-decahydroxy-19-{[1-hydroxy-4-methyl-2-(methylamino)pentylidene]amino}-22-[(C-hydroxycarbonimidoyl)methyl]-36-{[(phosphonomethyl)amino]methyl}-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2,.2,.1,.1,.0,.0,]pentaconta-3,5,8,10,12(48),14,16,20,23,26,29(45),30,32,34,36,38,41,43,46,49-icosaene-40-carboxylate
N(3'')-[2-(DECYLAMINO)ETHYL]-29-{[(PHOSPHONOMETHYL)AMINO]METHYL}VANCOMYCIN
TD-6424
Telavancin
|
Telavancina
Télavancine
Telavancinum
|
|
25 |
|
Caffeine |
Approved |
Phase 2, Phase 3 |
|
58-08-2 |
2519 |
Synonyms:
1,3,7-TRIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-TRIMETHYLPURINE-2,6-QUINONE
1,3,7-Trimethylxanthine
137X
1-Methyltheobromine
1-Methyl-theobromine
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
7-Methyl theophylline
7-Methyltheophylline
Alert-Pep
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anoquan
Berlin-chemie brand OF caffeine
Bristol-myers squibb brand OF caffeine
Cafamil
CAFCIT
Cafecon
Cafeina
Cafeína
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeine
CAFFEINE MELTING POINT STANDARD
Caffeine Pure
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeinum
Caffine
Cafipel
CFF
Coffein
COFFEINE
Coffeinum
Coffeinum N
Coffeinum purrum
Compound 65
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
Durvitan
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA NO. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
Guaranine
Hycomine
Invagesic
|
Invagesic Forte
Keep Alert
Kofein
Koffein
Lanorinal
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura brand OF caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Migergot
Miudol
Monohydrate caffeine
Monomethyl Derivative of Theophylline
Natural Caffeinum
Nix Nap
No doz
Nodaca
No-Doz
NODOZ
NODOZ CAPLETS AND CHEWABLE TABLETS
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC-5036
Organex
Orphengesic
Orphengesic Forte
Passauer brand OF caffeine
Pep-Back
Percoffedrinol N
Percutaféine
Peyona®
Phensal
Pierre fabre brand OF caffeine
PRO-PLUS
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick pep
Quick-pep
QuickPep
Refresh'n
Republic drug brand OF caffeine
Respia
Seid brand OF caffeine
SK 65 Compound
Stim
Synalgos-Dc
Teina
Teína
Thein
Theine
Theobromine ME
Theophylline ME
Thompson brand 1 OF caffeine
Thompson brand 2 OF caffeine
Triad
Ultra Pep-Back
Vivarin
Wake-Up
Wigraine
YEAST-VITE
ZANTHINE
|
|
26 |
|
Mupirocin |
Approved, Investigational, Vet_approved |
Phase 3 |
|
12650-69-0 |
446596 |
Synonyms:
14C-Labeled mupirocin
9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3- [(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2-YL]METHYL] OXAN-2-YL]-3-METHYLBUT-2-ENOYL]OXYNONANOIC ACID
Acid, pseudomonic
Bactroban
BRL 4910a
BRL-4910a
Centany
MRC
MUP
MUPIROCIN
Mupirocin calcium
Mupirocin, 14C labeled
|
Mupirocin, 14C-labeled
Mupirocin, calcium salt (2:1)
Mupirocin, calcium salt (2:1), dihydrate
Mupirocin, lithium salt
Mupirocin, sodium salt
Mupirocina
Mupirocine
Mupirocinum
Pseudomonate a
Pseudomonic acid
Pseudomonic acid a
|
|
27 |
|
Ciprofloxacin |
Approved, Investigational |
Phase 2, Phase 3 |
|
85721-33-1, 93107-08-5 |
2764 |
Synonyms:
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylate
1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylIC ACID
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
Anhydrous, ciprofloxacin hydrochloride
Bacquinor
BAY O 9867 FREE BASE
Baycip
BAY-O-9867 FREE BASE
BAYQ3939
BAY-Q-3939
Bernoflox
CETRAXAL
Ciflox
Cifloxin
CILOXAN
Ciprinol
Cipro
Cipro I.V.
Cipro XL
Cipro XR
CIPROBAY
|
Ciprocinol
Ciprodar
Ciprofloxacin
Ciprofloxacin dihydrochloride
Ciprofloxacin HCl
Ciprofloxacin hydrochloride
Ciprofloxacin hydrochloride anhydrous
Ciprofloxacin monohydrochloride
Ciprofloxacin monohydrochloride monohydrate
Ciprofloxacina
Ciprofloxacine
Ciprofloxacino
Ciprofloxacinum
Cipromycin
Ciproquinol
Ciproxan
Ciproxin
CPFX
CPR867
Flociprin
Floxin
Hydrochloride anhydrous, ciprofloxacin
Hydrochloride, ciprofloxacin
Monohydrate, ciprofloxacin monohydrochloride
Monohydrochloride monohydrate, ciprofloxacin
Ocuflox
OTIPRIO
Proquin XR
Septicide
VELMONIT
Velomonit
|
|
28 |
|
Levofloxacin |
Approved, Investigational |
Phase 2, Phase 3 |
|
100986-85-4 |
149096 |
Synonyms:
(-)-Ofloxacin
(2S)-7-FLUORO-2-METHYL-6-(4-METHYLPIPERAZIN-1-YL)-10-OXO-4-OXA-1-AZATRICYCLO[7.3.1.0^{5,13}]TRIDECA-5(13),6,8,11-TETRAENE-11-CARBOXYLIC ACID
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylate
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylate
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
Anhydrous, levofloxacin
Cravit
DR-3355
EVOXIL
FLOXACIN
Floxin
IQUIX
Levaquin
|
LEVOFLOXACIN
Levofloxacin anhydrous
LEVOFLOXACIN HEMIHYDRATE
Levofloxacin hydrate
Levofloxacine
Levofloxacino
Levofloxacinum
L-Ofloxacin
Ofloxacin
Ofloxacin S-(-)-form
OFLOXACIN S-(-)-FORM HEMIHYDRATE
Ofloxacin, (S)-isomer
OFTAQUIX
QUINSAIR
Quixin
RWJ-25213
TAVANIC
|
|
29 |
|
Ofloxacin |
Approved |
Phase 2, Phase 3 |
|
82419-36-1 |
4583 |
Synonyms:
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylate
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
Akilen
Baccidal
Bactocin
Danoflox
DL-8280
Effexin
EXOCIN
Exocine
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
FLOXIN OTIC
Floxstat
Fugacin
Hoe 280
Hoe-280
Inoflox
J01MA01
Kinflocin
Kinoxacin
Liflox
Loxinter
Marfloxacin
Medofloxine
Mergexin
Novecin
Nufafloqo
Obide
Occidal
OCUFLOX
Ofcin
Oflin
Oflocee
Oflocet
|
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
O-Flox
OFLOXACIN
Ofloxacin hydrochloride
Ofloxacine
Ofloxacino
Ofloxacinum
Ofloxin
OFLX
Ofus
Onexacin
Operan
Orocin
Otonil
Pharflox
Praxin
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Sinflo
Tabrin
Taravid
Tariflox
Tarivid
TARIVID 400
TARIVID I.V.
Telbit
Tructum
Uro Tarivid
Viotisone
VISIREN
Zanocin
|
|
30 |
|
Imipenem |
Approved |
Phase 3 |
|
74431-23-5, 64221-86-9 |
104838 |
Synonyms:
(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate
(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate
(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5R,6S)-3-(2-Formimidoylamino-ethylsulphanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate
(5R,6S)-3-(2-Formimidoylamino-ethylsulphanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure
Anhydrous imipenem
Anhydrous, imipenem
Imipemide
IMIPENEM
|
Imipenem anhydrous
Imipenem, anhydrous
Imipenem, N-formimidoyl thienamycin
Imipenemum
IMP
IPM
MK-0787
N Formimidoylthienamycin
N-Formimidoyl thienamycin
N-Formimidoylthienamycin
|
|
31 |
|
Meropenem |
Approved, Investigational |
Phase 3 |
|
119478-56-7, 96036-03-2 |
441130 |
Synonyms:
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylIC ACID
(2S,3R,4R)-2-[(1S,2R)-1-CARBOXY-2-HYDROXYPROPYL]-4-{[(3S,5R)-5-(DIMETHYLCARBAMOYL)PYRROLIDIN-3-YL]SULFANYL}-3-METHYL-3,4-DIHYDRO-2H-PYRROLE-5-CARBOXYLIC ACID
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
Antibiotic SM 7338
ICI-194660
MEPM
Meronem
MEROPENEM
Meropenem anhydrous
|
MEROPENEM HYDRATE
MEROPENEM TRIHYDRATE
Meropenemum
MEROPENEMUM TRIHYDRICUM
Merrem
Merrem i.v.
MERREM IV
Penem
Ronem
SM-7338
ZD3591
|
|
32 |
|
Cilastatin |
Approved, Investigational |
Phase 3 |
|
82009-34-5 |
6435415 |
Synonyms:
(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoate
(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid
(L)-7-(2-Amino-2-carboxy-ethylsulphanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoate
(L)-7-(2-Amino-2-carboxy-ethylsulphanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid
(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine
(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoate
(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid
(Z)-7-((R)-2-Amino-2-carboxy-ethylsulphanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoate
(Z)-7-((R)-2-Amino-2-carboxy-ethylsulphanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid
CILASTATIN
|
Cilastatin monosodium salt
Cilastatin sodium
Cilastatina
Cilastatine
Cilastatinum
MK 0791
Monosodium salt, cilastatin
PRIMAXIN
Salt, cilastatin monosodium
Sodium, cilastatin
|
|
33 |
|
Diazepam |
Approved, Illicit, Investigational, Vet_approved |
Phase 3 |
|
439-14-5 |
3016 |
Synonyms:
7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one
Alboral
Aliseum
Alupram
ALUPRAM 10
ALUPRAM 2
ALUPRAM 5
Amiprol
An-Ding
Ansiolin
Ansiolisina
Apaurin
Apo-Diazepam
APOZEPAM
Armonil
Assival
ATENSINE
Atilen
Bensedin
Bialzepam
Calmocitene
Calmpose
Cercine
Ceregulart
DAP
Diacepan
Dialag
DIALAR
DIALAR FTE
Diapam
Diastat
DIASTAT ACUDIAL
Diastat®|LA-III|Valium®|WY-3467
Diazemuls
Diazemulus
Diazepam
DIAZEPAM CIV
DIAZEPAM INTENSOL
Diazepan
Diazetard
Dienpax
Dipam
Dipezona
DIZAC
Domalium
Duksen
Duxen
E-PAM
Eridan
Eurosan
Evacalm
Faustan
Faustan,
Freudal
Frustan
Gewacalm
Gihitan
Kabivitrum
Kiatrium
LA III
LA-III
Lamra
Lembrol
Levium
Liberetas
Mandrozep
Methyl diazepinone
Methyldiazepinone
Morosan
|
Neurolytril
Noan
Novazam
Novo-Dipam
NRL-1
NSC-169897
NSC-77518
Paceum
Pacitran
Paranten
Paxate
PAXEL
Plidan
Pms-Diazepam
Pro-Pam
Q-PAM
Q-Pam Relanium
Quetinil
Quiatril
Quievita
Relaminal
Relanium
Renborin
RO-52807
RO-5-2807
Ruhsitus
Saromet
SCRIPTOPAM
Sedapam
Sedipam
Seduksen
Seduxen
SERENACK
Serenamin
Serenzin
Servizepam
Setonil
Sibazon
Sibazone
SOLIS
Sonacon
Stesolid
Stesolin
TENSIUM
Tensopam
TRANIMUL
Tranqdyn
Tranquase
Tranquirit
Tranquo-Puren
Tranquo-Tablinen
Umbrium
Unisedil
Usempax Ap
Valaxona
VALCLAIR
Valeo
Valiquid
Valitran
Valium
VALRELEASE
Vatran
Velium
Vival
VIVOL
WY-3467
Zetran
Zipan
|
|
34 |
|
Chlorhexidine |
Approved, Vet_approved, Withdrawn |
Phase 3 |
|
55-56-1 |
2713 9552079 |
Synonyms:
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
AVAGARD
CHLORHEXIDIN
CHLORHEXIDIN [CZECH]
CHLORHEXIDINE
CHLORHEXIDINUM
CHLORHEXIDINUM [INN-LATIN]
Cloresidina
CLORESIDINA [DCIT]
CLORHEXIDINA
CLORHEXIDINA [INN-SPANISH]
|
Dentisept
EXIDINE
HIBISTAT
Merfen-incolore
N-(4-CHLOROPHENYL)-1-3-(6-{N-[3-(4-CHLOROPHENYL)CARBAMIMIDAMIDOMETHANIMIDOYL]AMINO}HEXYL)CARBAMIMIDAMIDOMETHANIMIDAMIDE
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NOLVASAN
PERIDEX
STERILON
SUTHOL
SUTHOOOL
|
|
35 |
|
Ethanol |
Approved |
Phase 3 |
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
36 |
|
Fusidic acid |
Approved, Investigational |
Phase 3 |
|
6990-06-3 |
3000226 |
Synonyms:
(-)-Fusidate
Acid, fusidic
Acide fusidique
Acido fusidico
Acidum fusidicum
Diethanolamine fusidate
FA
Fucidate
Fucidic acid
Fucidin acid
Fucithalmic
Fusidate
|
Fusidate sodium
Fusidate, silver
Fusidate, sodium
Fusidic acid
Fusidic acid, sodium salt
Fusidin
Fusidine
Ramycin
Silver fusidate
Sodium fusidate
Sodium, fusidate
Stanicide
|
|
37 |
|
Ceftobiprole medocaril |
Approved, Experimental, Investigational |
Phase 3 |
|
376653-43-9 |
139292184 |
Synonyms:
7-{[1-hydroxy-2-(hydroxyimino)-2-(5-imino-4,5-dihydro-1,2,4-thiadiazol-3-yl)ethylidene]amino}-3-[(1'-{[(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methoxy]carbonyl}-2-oxo-[1,3'-bipyrrolidine]-3-ylidene)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Ceftobiprole medocaril
|
Ceftobiprole medocaril free acid
Ceftobiprole medocaril sodium
|
|
38 |
|
Ceftobiprole |
Approved, Investigational |
Phase 3 |
|
209467-52-7 |
139595999 |
Synonyms:
7-{[1-hydroxy-2-(hydroxyimino)-2-(5-imino-4,5-dihydro-1,2,4-thiadiazol-3-yl)ethylidene]amino}-8-oxo-3-({2-oxo-[1,3'-bipyrrolidine]-3-ylidene}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
BAL9141-000
BAL-9141000
BAL-9141-000
Ceftobiprol
|
CEFTOBIPROLE
RO-639141
RO-63-9141
ZEFTERA
ZEVTERA
|
|
39 |
|
Ceftazidime |
Approved |
Phase 3 |
|
78439-06-2, 72558-82-8 |
5481173 |
Synonyms:
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Anhydrous, ceftazidime
CAZ
Ceftazidim
Ceftazidima
Ceftazidime
CEFTAZIDIME (ARGININE FORMULATION)
Ceftazidime anhydrous
CEFTAZIDIME HYDRATE
Ceftazidime pentahydrate
Ceftazidimum
Ceptaz
|
FORTAM
Fortaz
Fortum
GR-20263
J01DD07
KEFAZIM
LY 139381
LY-139381
PENTACEF
Pentahydrate, ceftazidime
TAZICEF
Tazidime
|
|
40 |
|
Clindamycin |
Approved, Vet_approved |
Phase 3 |
|
18323-44-9, 24729-96-2 |
29029 |
Synonyms:
7 Chloro 7 deoxylincomycin
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-Chloro-7-deoxylincomycin
ANTIROBE
Chlolincocin
Chlorlincocin
CHLORODEOXYLINCOMYCIN
CHLOROLINCOMYCIN
CLDM
Cleocin
Cleocin Hcl
Cleocin Pediatric
Cleocin Phosphate
CLEOCIN T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
Clinda-Derm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
CLINDAMYCIN
Clindamycin Hcl
Clindamycin hydrochloride
Clindamycin monohydrochloride
Clindamycin monohydrochloride, monohydrate
|
Clindamycin phosphate
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Evoclin
Hydrochloride, clindamycin
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-a-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside
Monohydrate clindamycin monohydrochloride
Monohydrochloride, clindamycin
Monohydrochloride, monohydrate clindamycin
ResiDerm A
SOBELIN
U-21251
Zindaclin
|
|
41 |
|
Metronidazole |
Approved |
Phase 3 |
|
443-48-1, 69198-10-3 |
4173 |
Synonyms:
1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(b-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(b-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(b-Oxyethyl)-2-methyl-5-nitroimidazole
1-(Β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(Β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(Β-oxyethyl)-2-methyl-5-nitroimidazole
2 Methyl 5 nitroimidazole 1 ethanol
2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-5-nitroimidazole-1-ethanol
ACEA
Acromona
ANABACT
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAY-5360
Bayer 5360
BAYER-5360
Bexon
Clont
Cont
Danizol
Deflamon
Deflamon-Wirkstoff
DRAZIFON
Efloran
ELYZOL
Entizol
Eumin
Flagemona
Flagesol
Flagil
Flagyl
FLAGYL 375
FLAGYL COMPAK
FLAGYL ER
Flagyl I.V.
FLAGYL I.V. RTU IN PLASTIC CONTAINER
FLAGYL-400
FLAGYL-S
Flegyl
Fossyol
Giatricol
Gineflavir
Hydrochloride, metronidazole
Klion
Klont
Meronidal
Methronidazole
Metric
METRIC 21
Metro Cream
Metro I.V.
Metro I.V. In Plastic Container
METRO IV
METROCREAM
Metrodzhil
MetroGel
Metrogel-vaginal
Metrogyl
Metrolag
METROLOTION
METROLYL
|
METROMIDOL
Metronidaz
Metronidazol
METRONIDAZOLE
Métronidazole
Metronidazole benzoate
Metronidazole Hcl
Metronidazole hydrochloride
Metronidazole in plastic container
Metronidazole monohydrochloride
Metronidazole phosphate
Metronidazole phosphoester
Metronidazolo
Metronidazolum
METROSA
METROTOP
Mexibol
Monagyl
Monasin
Monohydrochloride, metronidazole
Nalox
Neo-Tric
NEUTRATOP
Nida
Nidagel
Noritate
Noritic acid
NORZOL
Novonidazol
NSC-50364
NSC-69587
NUVESSA
Orvagil
Phosphate, metronidazole
Phosphoester, metronidazole
PROTOSTAT
Rathimed
ROSICED
ROZEX
RP-8823
Sanatrichom
Satric
Takimetol
Trichazol
Trichex
Tricho Cordes
Trichocide
Tricho-Gynaedron
Trichomol
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
Vagilen
Vagimid
VAGINYL
VANDAZOLE
Vertisal
Wagitran
ZADSTAT
ZIDOVAL
ZYOMET
|
|
42 |
|
Oxacillin |
Approved, Investigational |
Phase 3 |
|
66-79-5 |
6196 |
Synonyms:
(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(5-Methyl-3-phenyl-4-isoxazolyl)penicillin
5-Methyl-3-phenyl-4-isoxazolyl-penicillin
6b-(5-Methyl-3-phenylisoxazol-4-yl)penicillanate
6b-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid
6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanate
6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid
6Β-(5-methyl-3-phenylisoxazol-4-yl)penicillanate
6Β-(5-methyl-3-phenylisoxazol-4-yl)penicillanic acid
BACTOCILL
Methylphenylisoxazolyl penicillin
Ossacillina
Oxacilina
|
OXACILLIN
Oxacillin sodium
Oxacillin, monosodium salt, anhydrous
Oxacillin, monosodium salt, monohydrate
Oxacillin, sodium
OXACILLINE
OXACILLINUM
Oxazocillin
Oxazocilline
Penicillin, methylphenylisoxazolyl
Prostaphlin
Sodium oxacillin
Sodium, oxacillin
|
|
43 |
|
Teicoplanin |
Approved, Investigational |
Phase 3 |
|
61036-62-2 |
16170201 |
Synonyms:
22-Amino-5,15-dichloro-64-({4,5-dihydroxy-3-[(1-hydroxydecylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-2-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-21,26,31,35,38,44,49,54,56,59-decahydroxy-47-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7,13,28-trioxa-20,36,39,53,55,58-hexaazaundecacyclo[38.14.2.2,.2,.2,.1,.1,.1,.1,.0,.0,]hexahexaconta-3,5,8,10,12(64),14,16,20,23(61),24,26,29(60),30,32,35,38,41(57),42,44,46(51),47,49,53,55,58,62,65-heptacosaene-52-carboxylate
MDL-507
TARGOCID
Teichomycin A2
|
TEICOPLANIN
teicoplanina
téicoplanine
teicoplaninum
|
|
44 |
|
Cefadroxil |
Approved, Vet_approved, Withdrawn |
Phase 3 |
|
66592-87-8, 50370-12-2 |
47965 |
Synonyms:
(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
4 Hydroxycephalexin
4-Hydroxycephalexin
Anhydrous, cefadroxil
BAXAN
Bidocef
BL S 578
BL S578
BLS 578
BL-S 578
BL-S578
CDX
CEFADROPS
CEFADROXIL
|
Cefadroxil anhydrous
Cefadroxil monohydrate
CEFADROXIL/CEFADROXIL HEMIHYDRATE
Cefadroxilo
Cefadroxilum
CEFATABS
Cefradroxil
Cephadroxil
Cephadroxyl
D-Cefadroxil
Duricef
MJF-11567-3
Monohydrate, cefadroxil
Sumacef
Ultracef
|
|
45 |
|
Aztreonam |
Approved |
Phase 3 |
|
78110-38-0 |
5742832 |
Synonyms:
(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfO-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionate
(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfO-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid
(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulphO-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionate
(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulphO-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid
2-({[(1Z)-1-(2-AMINO-1,3-THIAZOL-4-YL) -2- {[(2S,3S)-2-METHYL-4-OXO-1-SULFOAZETIDIN-3-YL]AMINO} -2- OXOETHYLIDENE]AMINO}OXY)-2-METHYLPROPANOIC ACID
Az threonam
Azactam
AZT
Azthreonam
Az-threonam
AZTREONAM
AZTRÉONAM
Aztreonam esteve brand
Aztreonam squibb brand
|
Aztreonamum
Bristol myers squibb brand OF aztreonam
Bristol-myers squibb brand OF aztreonam
CAYSTON
Esteve brand OF aztreonam
Monobactam
NSC-646279
Primbactam
Sanofi winthrop brand OF aztreonam
SO-26776
SQ 26776
SQ-26776
Squibb brand OF aztreonam
Urobactam
|
|
46 |
|
Norgestimate, ethinyl estradiol drug combination |
|
Phase 3 |
|
|
|
47 |
|
Vaccines |
|
Phase 3 |
|
|
|
48 |
|
Cephalosporins |
|
Phase 3 |
|
|
|
49 |
|
Immunoglobulins |
|
Phase 3 |
|
|
|
50 |
|
Antibodies |
|
Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 133)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Oral Flucloxacillin Alone Versus Flucloxacillin and Phenoxymethylpenicillin for the Emergency Department Outpatient Treatment of Cellulitis: a Non-inferiority Randomised Controlled Trial. |
Unknown status |
NCT02922686 |
Phase 4 |
Flucloxacillin;Phenoxymethylpenicillin;Placebo (for phenoxymethylpenicillin) |
2 |
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence |
Unknown status |
NCT02566928 |
Phase 4 |
2% mupirocin ointment |
3 |
A Double Blind Randomised Control Trial to Measure the Effect of the Addition of Clindamycin to Flucloxacillin for the Treatment of Limb Cellulitis |
Completed |
NCT01876628 |
Phase 4 |
Flucloxacillin;Clindamycin;Placebo oral capsule |
4 |
Randomised Controlled Trial to Investigate Whether Prophylactic Antibiotics Can Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg (PATCH I) |
Completed |
NCT00552799 |
Phase 4 |
Penicillin VK |
5 |
Effects of Daptomycin in the Levels of IL-1, IL-6 and TNF in Patients With Complicated Cellulitis/Erisipela in Comparison With Vancomycin or Oxacillin |
Completed |
NCT01626560 |
Phase 4 |
Daptomycin;Vancomycin |
6 |
High-dose Cephalexin for Cellulitis: A Pilot Randomized Controlled Trial |
Completed |
NCT04471246 |
Phase 4 |
Cephalexin |
7 |
A Multicenter, Randomized Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in the Treatment of Cellulitis or Erysipelas |
Completed |
NCT00295178 |
Phase 4 |
Daptomycin;Vancomycin |
8 |
Randomized Clinical Trial of Wound Packing Following Incision and Drainage of Superficial Skin Abscesses in the Pediatric Emergency Department |
Completed |
NCT00746109 |
Phase 4 |
|
9 |
Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections |
Completed |
NCT01549613 |
Phase 4 |
Daptomycin;Vancomycin |
10 |
Clinical and Economic Outcomes of Ceftaroline Fosamil for the Treatment of Acute Bacterial Skin and Skin Structure Infections Documented or at Risk of Methicillin-Resistant S. Aureus |
Completed |
NCT02582203 |
Phase 4 |
Ceftaroline;Vancomycin |
11 |
The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown |
Completed |
NCT03929224 |
Phase 4 |
Medicinal honey;Bacitracin |
12 |
An Open-Label, Non-Comparative Study to Assess the Pharmacokinetics, Safety and Efficacy of Topical Retapamulin (SB-275833) Ointment, 1%, Twice Daily for Five Days in the Treatment of Uncomplicated Skin and Skin Structure Infections in Pediatric Subjects Aged 2 to 24 Months |
Completed |
NCT00555061 |
Phase 4 |
Retapamulin Ointment, 1% |
13 |
Comparison of Cephalexin Versus Clindamycin in the Empiric, Outpatient Treatment of Suspected Staphylococcal Cutaneous Infections in the Era of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) |
Completed |
NCT00352612 |
Phase 4 |
clindamycin;cephalexin |
14 |
A Randomized Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization, and Cost of Daptomycin vs. Vancomycin in the Treatment of Patients With Complicated Skin and Skin Structure Infections Due to Suspected or Documented Methicillin-resistant Staphylococcus Aureus (MRSA) |
Completed |
NCT01419184 |
Phase 4 |
Daptomycin;Vancomycin |
15 |
Using a Cold Atmospheric Plasma Device to Treat Molluscum Contagiosum and Verruca Vulgaris in Pediatric Patients |
Recruiting |
NCT05070754 |
Phase 4 |
Canthardin Collodion |
16 |
Duration of Antibiotic Therapy for Cellulitis (DANCE): a Randomized Controlled Trial Comparing 6 to 12 Days of Antibiotic Therapy for Patients Hospitalized With Cellulitis |
Terminated |
NCT02032654 |
Phase 4 |
Flucloxacillin;Placebo (for flucloxacillin) |
17 |
A Multicentre, Open Label, Uncontrolled Clinical Trial to Evaluate Efficacy and Safety of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections (cSSTI) Caused by Methicillin-resistant Staphylococcus Aureus (MRSA) |
Terminated |
NCT00463801 |
Phase 4 |
Daptomycin |
18 |
Hospital Avoidance Strategies for Treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) |
Terminated |
NCT03372941 |
Phase 4 |
Dalbavancin |
19 |
Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department |
Unknown status |
NCT00323219 |
Phase 3 |
Cefazolin and Moxifloxacin |
20 |
A Pilot Randomized Controlled Trial Assessing the Effectiveness of Alcohol Swabs in Preventing Infections in Pediatric Patients Receiving Vaccinations |
Unknown status |
NCT03131843 |
Phase 3 |
Alcohol;No alcohol |
21 |
A Phase 3b, Double-Blind, Multicenter, Randomized Study to Compare the Efficacy and Safety of Single Dose Dalbavancin to a Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
Completed |
NCT02127970 |
Phase 3 |
Dalbavancin;Dalbavancin-matching Placebo |
22 |
Ultrasound Guided Needle Drainage Versus Formal Incision and Drainage of Superficial Soft Tissue Abscesses in the Emergency Department Setting |
Completed |
NCT01085929 |
Phase 3 |
|
23 |
The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy. |
Completed |
NCT03556917 |
Phase 2, Phase 3 |
|
24 |
A Multicenter, Active-Controlled, Randomized Study to Evaluate the Safety and Efficacy of Levofloxacin Versus Ciprofloxacin HCl in the Treatment of Mild to Moderate Skin and Skin Structure Infections in Adults |
Completed |
NCT00257036 |
Phase 2, Phase 3 |
levofloxacin |
25 |
A Multicenter, Randomized, Double Blind, Comparative Trial of Intravenous MERREM (Meropenem, ICI 194,660) vs PRIMAXIN I.V. (Imipenem-cilastatin) in the Treatment of Hospitalised Subjects With Complicated Skin and Skin Structure Infections. |
Completed |
NCT00619710 |
Phase 3 |
Meropenem;Imipenem-cilastatin |
26 |
A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection (SOLO II) |
Completed |
NCT01252732 |
Phase 3 |
Single-Dose IV Oritavancin Diphosphate;IV Vancomycin |
27 |
A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection (SOLO I) |
Completed |
NCT01252719 |
Phase 3 |
Single-Dose IV Oritavancin Diphosphate;IV Vancomycin;Placebo |
28 |
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Dalbavancin to a Comparator Regimen (Vancomycin and Linezolid) for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
Completed |
NCT01431339 |
Phase 3 |
IV Dalbavancin;Vancomycin/Linezolid |
29 |
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Dalbavancin to a Comparator Regiment (Vancomycin and Linezolid) for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
Completed |
NCT01339091 |
Phase 3 |
Dalbavancin;Vancomycin / Linezolid |
30 |
A Three-part,Multicenter Study,With a Randomized,Double-blind,Placebo Controlled,Withdrawal Design in Part II to Assess Efficacy,Safety,and Tolerability of ACZ885(Anti-interleukin-1beta Monoclonal Antibody)in Patients With Muckle-Wells Syndrome |
Completed |
NCT00465985 |
Phase 3 |
ACZ885;Placebo |
31 |
A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus Aureus |
Completed |
NCT00852540 |
Phase 3 |
Retpamulin Ointment, 1%;Linezolid |
32 |
An Open-label, Long-term Safety and Efficacy Study of ACZ885 (Anti-interleukin-1β Monoclonal Antibody) Administered for at Least 6 Months in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease |
Completed |
NCT00685373 |
Phase 3 |
Canakinumab (ACZ885) |
33 |
A Randomized, Double-Blind, Multicenter, Placebo-controlled, Phase III Superiority Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Placebo Ointment Applied Twice Daily for 5 Days in the Treatment of Adult and Pediatric Subjects With SITL |
Completed |
NCT00684177 |
Phase 3 |
Retapamulin Ointment, 1%;Placebo ointment |
34 |
An Observer-blind, Multicenter, Non-inferiority, Comparative Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, Versus Topical 2% Fusidic Acid Cream Applied Three Times Daily for 7 Days in the Treatment Adult and Paediatric Subjects With Impetigo |
Completed |
NCT00133874 |
Phase 3 |
SB-275833 ointment, 1% |
35 |
A Phase 3, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram Positive Skin and Skin Structure Infections With a Focus on Patients With Infections Due to Methicillin-resistant Staphylococcus Aureus |
Completed |
NCT00107978 |
Phase 3 |
Telavancin;Vancomycin |
36 |
A Phase III, Randomized, Double-Blind Study of Ceftobiprole Versus Comparator in the Treatment of Complicated Skin and Skin Structure Infections |
Completed |
NCT00210899 |
Phase 3 |
ceftobiprole medocaril;Vancomycin plus Ceftazidime |
37 |
A Phase III, Randomized, Double-Blind Study of Ceftobiprole Versus Comparator in the Treatment of Complicated Skin and Skin Structure Infections |
Completed |
NCT00228982 |
Phase 3 |
Ceftobiprole medocaril;Vancomycin |
38 |
An Open-label, Efficacy and Safety Study of Canakinumab (Anti-interleukin-1β Monoclonal Antibody) Administered for 6 Months (24 Weeks) in Japanese Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease, Followed by an Extension Phase to Provide Canakinumab to Study Patients Until it is Approved and Marketed in Japan |
Completed |
NCT00991146 |
Phase 3 |
canakinumab |
39 |
A Phase 3, Randomized, Double Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram Positive Skin and Skin Structure Infections With a Focus on Patients With Infections Due to Methicillin-resistant Staphylococcus Aureus |
Completed |
NCT00091819 |
Phase 3 |
Telavancin;Vancomycin |
40 |
Evaluation of Novel Antimicrobial Hand Towels |
Completed |
NCT02512614 |
Phase 2, Phase 3 |
|
41 |
A 2X2 Phase III Open-label Clinical Trial of Therapy for Patients With Recurrent Methicillin Resistant Staphylococcus Aureus Infections: Topical Nasal & Body Decolonization and/or Environmental Decontamination vs. Standard of Care |
Completed |
NCT00560599 |
Phase 3 |
mupirocin and chlorhexidine;mupirocin, chlorhexidine, & household cleaning/disinfection |
42 |
An Open-label Extension Study to Assess Efficacy, Safety and Tolerability of Canakinumab and the Efficacy and Safety of Childhood Vaccinations in Patients With Cryopyrin Associated Periodic Syndromes (CAPS) |
Completed |
NCT01576367 |
Phase 3 |
|
43 |
A One-year Open-label, Multicenter Trial to Assess Efficacy, Safety and Tolerability of Canakinumab (ACZ885) and the Efficacy and Safety of Childhood Vaccinations in Patients Aged 4 Years or Younger With Cryopyrin Associated Periodic Syndromes (CAPS) |
Completed |
NCT01302860 |
Phase 3 |
ACZ885 |
44 |
A Phase 3, Multicenter, Open-Label, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections |
Recruiting |
NCT02814916 |
Phase 3 |
Dalbavancin single dose;Dalbavancin two dose;Comparator |
45 |
A Blinded, Non-inferiority Phase III Trial of 5 Versus 7 Days of Oral Flucloxacillin in Primary Care Patients With Lower Limb Cellulitis |
Not yet recruiting |
NCT05584007 |
Phase 3 |
Flucloxacillin Only Product in Oral Dose Form;Placebo Only Product in Oral Dose Form |
46 |
Intravenous Cefazolin Plus Oral Probenecid vs. Oral Cephalexin for the Treatment of Cellulitis: a Randomized Controlled Trial |
Completed |
NCT01029782 |
Phase 2 |
IV cefazolin plus oral probenecid and placebo cephalexin;Oral cephalexin and saline IV plus probenecid placebo |
47 |
A Randomized, Parallel Group, Controlled Study to Assess the Efficacy and Safety of NMBM in the Treatment of Subjects With a Post-cellulitis and Venous Leg Ulcer |
Completed |
NCT01770509 |
Phase 1, Phase 2 |
|
48 |
Phase 2 Open-Label Safety and Exploratory Skin Lesion Measurement Study of 6-Day Oral TR-701 FA in Skin Abscess and Cellulitis Patients |
Completed |
NCT01519778 |
Phase 2 |
TR701 FA |
49 |
Nuvocid® (Oritavancin) at Single or Infrequent Doses for the Treatment of Complicated Skin and Skin Structure Infections (SIMPLIFI) |
Completed |
NCT00514527 |
Phase 2 |
oritavancin |
50 |
A Phase 2, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Standard Therapy for Treatment of Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) |
Completed |
NCT00061633 |
Phase 2 |
Telavancin;Vancomycin or antistaphylococcal penicillin |
Cochrane evidence based reviews: cellulitis
|